Search research articles
Contact Us
Filters
Showing results (101-110 of 151) with videos related to
Page
of 16
Sort By:
Respiratory Research
|
June 26, 2022
Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study
Sebastiano Maria Colombo, Vittorio Scaravilli, Andrea Cortegiani, et al.
Haematologica
|
June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial
Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Hematological Oncology
|
September 26, 2020
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series
Alessandra Iurlo, Francesca Palandri, Elena Maria Elli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Massimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial
Emilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
American Journal of Hematology
|
August 28, 2014
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study
Paola Tacchetti, Carolina Terragna, Monica Galli, et al.
Leukemia & Lymphoma
|
September 8, 2011
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
Francesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
British Journal of Haematology
|
January 18, 2006
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
Andrea Rinaldi, Ivo Kwee, Monica Taborelli, et al.
British Journal of Haematology
|
January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)
Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 151) with videos related to
Sort By:
Page
of 16
Respiratory Research
|
June 26, 2022
Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study
Sebastiano Maria Colombo, Vittorio Scaravilli, Andrea Cortegiani, et al.
Haematologica
|
June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial
Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Hematological Oncology
|
September 26, 2020
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series
Alessandra Iurlo, Francesca Palandri, Elena Maria Elli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Massimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial
Emilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, et al.
American Journal of Hematology
|
August 28, 2014
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study
Paola Tacchetti, Carolina Terragna, Monica Galli, et al.
Leukemia & Lymphoma
|
September 8, 2011
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
Francesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
British Journal of Haematology
|
January 18, 2006
Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
Andrea Rinaldi, Ivo Kwee, Monica Taborelli, et al.
British Journal of Haematology
|
January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)
Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Page
of 16